By HOF Sonderanlagenbau…
To get in touch with HOF Sonderanlagenbau GmbH, simply fill out the form below.
Subscribe to Supplier
HOF Sonderanlagenbau showcasing CryoBlizzard technology at PDA Biomanufacturing Conference Seville
Lohra, Germany: Innovative force in high quality tailored lyophilization solutions, HOF Sonderanlagenbau, will be a high-profile presence at the upcoming PDA Biomanufacturing conference in Seville as one of the lead exhibitors at the event.
HOF has a long-standing relationship with the Parenteral Drug Association with a track record of attendance at PDA Europe events that extends back many years.
Future is Now
The HOF stand at Booth 4 in the Exhibition Zone at Seville’s Melia Lebreros Hotel will feature displays and technical information on its portfolio of highly advanced technologies and custom-tailored solutions for freeze drying, loading and unloading and freeze-thaw processing.
The HOF displays will highlight its innovative ‘Future is Now’ solutions such as the revolutionary CryoBlizzard technology that uses ambient air as a natural refrigerant, SmartVTS vial transfer system that combines robotic handling of vials with HOF’s wireless tempris© sensor system, alongside automatic machine protection, HOF SynchroFreeze, vacuum-induced ice nucleation and F-Gas regulation-compliant systems.
Reconnecting with PDA
HOF Sonderanlagenbau Sales Manager for Lyophilizer systems Dirk Walbrecht and Sales Manager for Loading and Unloading Systems Peter Schneider will lead the HOF exhibition team at the event.
Dirk Walbrecht commented: “The PDA Europe series of events are among the most influential for the freeze-drying sector and now form milestones on our calendar.”
“These meetings provide us with first-class opportunities for knowledge-sharing on the latest developments shaping lyophilization processes and technology as well as a networking platform to bring our latest developments and products to current and potential clients,” Mr. Walbrecht explained.
About HOF Sonderanlagenbau
HOF Sonderanlagenbau GmbH is a world-class and highly innovative special equipment manufacturer of lyophilization freeze-drying, freeze-thaw and loading/unloading systems for the pharmaceutical and healthcare industries.
Founded in 1988, this German family-owned company has become one of the world’s most respected names for high quality just in time freeze drying (lyophilization) solutions, with more than three decades of experience.
Sonderanlagenbau is German for ‘special equipment manufacture’ and in this case, refers to HOF’s lab scale, pilot scale and production scale freeze drying solutions, loading and unloading systems, and freeze-thaw units for the pharmaceutical, biotech and life science industries.
From its advanced manufacturing base at Lohra, north of Frankfurt, HOF designs and constructs specifically tailored freeze-drying and associated solutions for companies all over the world under its motto of “Just in time quality for demanding customers.”
HOF Sonderanlagenbau does not offer off-the-shelf products but has instead constructed a fully integrated total design and build environment in which every machine is unique, exactly specified in partnership with customer and manufactured to meet very specific requirements. The partnership ethos extends into ownership, with our comprehensive service and maintenance offerings designed to ensure that no one needs to work on a HOF machine except its own experts.
HOF is consistently named as one of the Top 100 most innovative companies in Germany.
Learn more at: www.hof-sonderanlagen.de/en/home/
About PDA BioManufacturing Conference 2023
The 2023 PDA BioManufacturing Conference is part of the Europe Exchange Series staged by the Parenteral Drug Association (PDA).
The PDA Biomanufacturing Conference 2023 is a two-day event opening September 12 at the Melia Lebreros Hotel in Seville, Spain.
The theme for the 2023 conference, ‘Agility and Biomanufacturing Excellence to Meet Patients’ Needs’, links the overall PDA goal of improving patient care with the pharma industry’s need to achieve sustained improvement and flexibility in biomanufacturing processes.
The conference agenda will cover topics such as vaccine delivery, monoclonal antibodies, and new drug modalities from early development until commercial cGMP manufacturing, with focus on product, process and analytical advances.
The event is organized by the Parenteral Drug Association with further information at: www.pda.org/global-event-calendar/event-detail/2023-pda-biomanufacturing-conference#overview
Click on HOF Focus on Your Product for more on innovative solutions.